Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its appointment of Summer (XiangYang) Yun as chief executive officer of its CBD Biotechnology Co., Ltd. subsidiary, which it originally launched in March of this year. Yun brings over 25 years of marketing and branding experience to the CIIX team. As CEO of CBD Biotechnology, Yun’s initial focus will be the launch of the ‘CBD Magic Hemp Series’ cosmetic line, and he will also spearhead the company’s plan to import natural dietary supplements into China. “I am honored to be named as CEO of CBD Biotech,” Yun stated in this morning’s news release. “For over 5,000 years, hemp has been cultivated and used in over 25,000 products worldwide. CIIX has a unique opportunity to become one of the first companies to offer CBD-based skin care products in China online and through established retail and direct selling channels. Through the introduction of Magic CBD Series cosmetics to China, I hope to educate consumers regarding hemp’s many benefits.” Yun will report directly to CIIX CEO Warren Wang moving forward.
Read the full article
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Read More
ChineseInvestors.com, Inc. (CIIX) Adds Summer Yun as CEO of CBD Biotechnology Co., Ltd.
